# Tafluprost

## Taflotan-S  0.0015%0.3mL ophthalmic solution

| 藥物代碼           | ETAFS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 副作用             | >10%: Ocular: Conjunctival hyperemia (4% to 20%)1% to 10%:Central nervous system: Headache (6%)Genitourinary: Urinary tract infection (2%) Ocular: Stinging/irritation (7%), conjunctivitis (5%), cataract (3%), dry eye (3%), ocular pain (3%), eyelash darkening (2%), eyelash growth (2%), vision blurred (2%)Respiratory: Common cold (4%), cough (3%) Postmarketing and/or case reports (Limited to important or life-threatening): Dyspnea, exacerbation of asthma; macular edema (reported with prostaglandin analog use) |
| 禁忌               | Hypersensitivity to Tafluprost.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 藥物保存方式       | 2-8度C                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 用法用量           | Glaucoma: Ophthalmic: One drop in the affected eye(s) once daily in the evening; do not exceed the once daily dosage because it has been shown that more frequent administration may decrease the IOP-lowering effect.                                                                                                                                                                                                                                                                                                           |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 孕期用藥建議       | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 注射劑給藥建議途徑 | OD, OL, OU                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

